-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Edesa Biotech, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2012 to Q2 2025.
- Edesa Biotech, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2025 was $30K, unchanged year-over-year.
- Edesa Biotech, Inc. annual Amortization of Intangible Assets for 2024 was $101B.
- Edesa Biotech, Inc. annual Amortization of Intangible Assets for 2023 was $101B.
- Edesa Biotech, Inc. annual Amortization of Intangible Assets for 2022 was $1.01B.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)